Home › Funds › Polaris Capital Management, LLC › JAZZ
Polaris Capital Management, LLC position in JAZZ
JAZZ PHARMACEUTICALS PLC · Health Care
Polaris Capital Management, LLC reported holding 320,466 shares of JAZZ (JAZZ PHARMACEUTICALS PLC) in its Q3 2026 13F filing — a position valued at US$74.2M, representing 7.78% of its reported portfolio and ranking #2 among its reported holdings. Polaris Capital Management, LLC has disclosed JAZZ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Polaris Capital Management, LLC's JAZZ position evolved
Polaris Capital Management, LLC first disclosed a stake in JAZZ in Q3 2023 at 1,240,360 shares (US$160.6M). The position peaked in Q1 2024 at 1,432,660 shares, worth US$172.5M. Across 13 filings, Polaris Capital Management, LLC increased the stake 2 time(s), trimmed it 10 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 320,466 shares valued at US$74.2M — a reduction of -8,500 shares quarter over quarter.. Notable position changes include a 28% trim in Q2 2025 (shares rose 24% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 1.24M | $160.55M | New |
| Q4 2023 | 1.27M | $155.90M | Add |
| Q1 2024 | 1.43M | $172.52M | Add |
| Q2 2024 | 1.38M | $146.80M | Reduce |
| Q3 2024 | 1.31M | $145.45M | Reduce |
| Q4 2024 | 1.09M | $133.72M | Reduce |
| Q1 2025 | 879.16K | $109.15M | Reduce |
| Q2 2025 | 634.16K | $67.30M | Reduce |
| Q3 2025 | 513.47K | $67.67M | Reduce |
| Q4 2025 | 432.47K | $73.52M | Reduce |
| Q1 2026 | 415.37K | $78.52M | Reduce |
| Q2 2026 | 328.97K | $79.27M | Reduce |
| Q3 2026 | 320.47K | $74.19M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About JAZZ and 13F data
JAZZ (JAZZ PHARMACEUTICALS PLC) is a Health Care company. 42 other funds we track also report a position in JAZZ — the largest reported positions include FULLER & THALER ASSET MANAGEMENT, INC. (US$394.8M), MILLENNIUM MANAGEMENT LLC (US$184.1M), GMT CAPITAL CORP (US$109.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding JAZZ
- FULLER & THALER ASSET MANAGEMENT, INC. 1.64M sh · $394.84M · Q2 2026
- MILLENNIUM MANAGEMENT LLC 763.88K sh · $184.07M · Q2 2026
- GMT CAPITAL CORP 453.50K sh · $109.28M · Q2 2026
- Boston Trust Walden Corp 424.57K sh · $98.30M · Q3 2026
More on Polaris Capital Management, LLC
FAQ
How long has Polaris Capital Management, LLC held JAZZ?
Polaris Capital Management, LLC has disclosed JAZZ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Polaris Capital Management, LLC's current position in JAZZ?
As of Q3 2026, Polaris Capital Management, LLC holds 320.47K shares of JAZZ (JAZZ PHARMACEUTICALS PLC), valued at $74.19M, representing 7.78% of its reported portfolio and ranking #2.
Has Polaris Capital Management, LLC been buying or selling JAZZ?
In the latest 13F filing (Q3 2026), Polaris Capital Management, LLC reduced its position in JAZZ. The position peaked in Q1 2024 at 1.43M shares.
Which other funds hold JAZZ?
Other major institutional holders of JAZZ include FULLER & THALER ASSET MANAGEMENT, INC., MILLENNIUM MANAGEMENT LLC, GMT CAPITAL CORP, among 42 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.